We are live on ! Find out more
SCM

Smead Capital Management Portfolio holdings

AUM $4.6B
1-Year Est. Return 27.56%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+27.56%
3 Year Est. Return
+64.97%
5 Year Est. Return
+125.46%
10 Year Est. Return
+462.58%
AUM
$830M
AUM Growth
+$104M
Cap. Flow
+$81.9M
Cap. Flow %
9.86%
Top 10 Hldgs %
52.31%
Holding
30
New
1
Increased
24
Reduced
2
Closed
2

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$17.9M
2
BMY icon
Bristol-Myers Squibb
BMY
+$10.3M
3
WBA
Walgreens Boots Alliance
WBA
+$2.16M
4
DIS icon
Walt Disney
DIS
+$1.06M

Sector Composition

Rank Sector Weight
1 Healthcare 32.34%
2 Financials 29.45%
3 Consumer Discretionary 20.79%
4 Communication Services 10.86%
5 Technology 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
26
Abbott
ABT
$185B
$12.5M 1.51%
324,738
+40,154
+14% +$1.55M
SBUX icon
27
Starbucks
SBUX
$119B
$11.4M 1.38%
311,824
+37,924
+14% +$1.4M
USB icon
28
US Bancorp
USB
$98.5B
$1.18M 0.14%
27,571
BMY icon
29
Bristol-Myers Squibb
BMY
$132B
-193,483
Closed -$10.3M
VTRS icon
30
Viatris
VTRS
$20.3B
-412,814
Closed -$17.9M

Similar funds

Smead Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, Smead Capital Management held 30 positions worth $830M, up 14% from $726M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Smead Capital Management deployed $81.9M of net new capital in Q1 2014, opening 1 new position and adding to 24 existing holdings. Its largest new stake was CHUBB CORPORATION: 195,561 shares worth $17.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $2.16M trimmed.

  • Smead Capital Management's largest Q1 2014 buy was CHUBB CORPORATION: 195,561 shares worth $17.5M.
  • Smead Capital Management added most to Berkshire Hathaway Class B in Q1 2014, an estimated $12.3M increase.
  • Smead Capital Management's biggest Q1 2014 reduction was Walgreens Boots Alliance, cutting an estimated $2.16M.
  • Smead Capital Management fully exited Viatris in Q1 2014, selling an estimated $17.9M.
  • Smead Capital Management's ten largest holdings make up 52% of its $830M portfolio in Q1 2014.
  • Smead Capital Management opened 1 new position and closed 2 in Q1 2014.
  • Smead Capital Management's portfolio value rose 14% quarter-over-quarter to $830M.

Based on Smead Capital Management's 13F filing for Q1 2014, filed 8 May 2014.